Enhancing recombinant antibody yield in Chinese hamster ovary cells
- PMID: 38993821
- PMCID: PMC11236083
- DOI: 10.4103/tcmj.tcmj_315_23
Enhancing recombinant antibody yield in Chinese hamster ovary cells
Abstract
A range of recombinant monoclonal antibodies (rMAbs) have found application in treating diverse diseases, spanning various cancers and immune system disorders. Chinese hamster ovary (CHO) cells have emerged as the predominant choice for producing these rMAbs due to their robustness, ease of transfection, and capacity for posttranslational modifications akin to those in human cells. Transient transfection and/or stable expression could be conducted to express rMAbs in CHO cells. To bolster the yield of rMAbs in CHO cells, a multitude of approaches have been developed, encompassing vector optimization, medium formulation, cultivation parameters, and cell engineering. This review succinctly outlines these methodologies when also addressing challenges encountered in the production process, such as issues with aggregation and fucosylation.
Keywords: Cell engineering; Chinese hamster ovary cells; Plasmid construction; Recombinant antibody.
Copyright: © 2024 Tzu Chi Medical Journal.
Conflict of interest statement
Dr. Shih-Yen Lo, an editorial board member at Tzu Chi Medical Journal, had no role in the peer review process or the decision to publish this article. The other authors declared no conflicts of interest in writing this paper.
Figures


Similar articles
-
Increase recombinant antibody yields through optimizing vector design and production process in CHO cells.Appl Microbiol Biotechnol. 2022 Aug;106(13-16):4963-4975. doi: 10.1007/s00253-022-12051-5. Epub 2022 Jul 5. Appl Microbiol Biotechnol. 2022. PMID: 35788878
-
Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells.Front Bioeng Biotechnol. 2022 Mar 4;10:856049. doi: 10.3389/fbioe.2022.856049. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35316944 Free PMC article. Review.
-
A BioDesign Approach to Obtain High Yields of Biosimilars by Anti-apoptotic Cell Engineering: a Case Study to Increase the Production Yield of Anti-TNF Alpha Producing Recombinant CHO Cells.Appl Biochem Biotechnol. 2018 Jan;184(1):303-322. doi: 10.1007/s12010-017-2540-2. Epub 2017 Jul 6. Appl Biochem Biotechnol. 2018. PMID: 28685239
-
Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production.Metab Eng. 2020 Jan;57:203-216. doi: 10.1016/j.ymben.2019.11.007. Epub 2019 Dec 2. Metab Eng. 2020. PMID: 31805379 Free PMC article.
-
Cell engineering and cultivation of chinese hamster ovary (CHO) cells.Curr Pharm Biotechnol. 2010 Apr;11(3):233-40. doi: 10.2174/138920110791111960. Curr Pharm Biotechnol. 2010. PMID: 20210750 Review.
Cited by
-
Construction of an Integration Vector with a Chimeric Signal Peptide for the Expression of Monoclonal Antibodies in Mammalian Cells.Curr Issues Mol Biol. 2024 Dec 22;46(12):14464-14475. doi: 10.3390/cimb46120868. Curr Issues Mol Biol. 2024. PMID: 39727996 Free PMC article.
References
-
- Stanfield RL, Wilson IA. Antibody structure. Microbiol Spectr. 2014;2 [doi: 10.1128/microbiolspec. AID-0012-2013] - PubMed
-
- Lim Y, Wong NS, Lee YY, Ku SC, Wong DC, Yap MG. Engineering mammalian cells in bioprocessing – Current achievements and future perspectives. Biotechnol Appl Biochem. 2010;55:175–89. - PubMed
-
- MacDonald MA, Nöbel M, Roche Recinos D, Martínez VS, Schulz BL, Howard CB, et al. Perfusion culture of Chinese hamster ovary cells for bioprocessing applications. Crit Rev Biotechnol. 2022;42:1099–115. - PubMed
-
- Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, et al. Monoclonal antibodies: A review. Curr Clin Pharmacol. 2018;13:85–99. - PubMed
Publication types
LinkOut - more resources
Full Text Sources